CV Sciences (CVSI) Equity Average (2011 - 2026)

CV Sciences has disclosed Equity Average across 16 years of filings, most recently posting $1.5 million for Q1 2026.

• Equity Average for Q1 2026 came in at $1.5 million, down 19.56% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.5 million (down 19.56% YoY), and the FY2025 annual result was $1.6 million, down 30.54% from the prior year.
• Equity Average came in at $1.5 million for Q1 2026 at CV Sciences, down from $1.5 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $4.5 million in Q2 2023 to a low of $294000.0 in Q4 2022.
• The 5-year median for Equity Average is $2.1 million (2023), against an average of $2.3 million.
• Across the five-year window, Equity Average slumped 96.0% in 2022 and jumped 985.37% in 2023, its largest moves.
• CV Sciences' Equity Average stood at $294000.0 in 2022, then surged by 985.37% to $3.2 million in 2023, then sank by 37.54% to $2.0 million in 2024, then fell by 24.56% to $1.5 million in 2025, then slipped by 1.36% to $1.5 million in 2026.
• The last three Equity Average figures came in at $1.5 million (Q1 2026), $1.5 million (Q4 2025), and $1.7 million (Q3 2025), per Business Quant data.